Literature DB >> 18523245

The innate NK cells, allograft rejection, and a key role for IL-15.

Alexander Kroemer1, Xiang Xiao, Nicolas Degauque, Karoline Edtinger, Haiming Wei, Gulcin Demirci, Xian Chang Li.   

Abstract

Transplant rejection is mediated primarily by adaptive immune cells such as T cells and B cells. The T and B cells are also responsible for the specificity and memory of the rejection response. However, destruction of allografts involves many other cell types including cells in the innate immune system. As the innate immune cells do not express germline-encoded cell surface receptors that directly recognize foreign Ags, these cells are thought to be recruited by T cells to participate in the rejection response. In this study, we examined the alloreactivity of the innate NK cells in Rag(-/-) mice using a stringent skin transplant model and found that NK cells at a resting state readily reject allogeneic cells, but not the skin allografts. We also found that IL-15, when preconjugated to its high affinity IL-15Ralpha-chain, is remarkably potent in stimulating NK cells in vivo, and NK cells stimulated by IL-15 express an activated phenotype and are surprisingly potent in mediating acute skin allograft rejection in the absence of any adaptive immune cells. Furthermore, NK cell-mediated graft rejection does not show features of memory responses. Our data demonstrate that NK cells are potent alloreactive cells when fully activated and differentiated under certain conditions. This finding may have important clinical implications in models of transplantation and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18523245     DOI: 10.4049/jimmunol.180.12.7818

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

Review 1.  An overview on non-T cell pathways in transplant rejection and tolerance.

Authors:  Wentao Liu; Xian C Li
Journal:  Curr Opin Organ Transplant       Date:  2010-08       Impact factor: 2.640

Review 2.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

Review 3.  The innate immune system in transplantation.

Authors:  Martin H Oberbarnscheidt; Daniel Zecher; Fadi G Lakkis
Journal:  Semin Immunol       Date:  2011-07-01       Impact factor: 11.130

4.  Densely granulated murine NK cells eradicate large solid tumors.

Authors:  Rebecca B Liu; Boris Engels; Ainhoa Arina; Karin Schreiber; Elizabeth Hyjek; Andrea Schietinger; David C Binder; Eric Butz; Thomas Krausz; Donald A Rowley; Bana Jabri; Hans Schreiber
Journal:  Cancer Res       Date:  2012-02-28       Impact factor: 12.701

5.  In Vivo Bioluminescence Imaging of Transplanted Mesenchymal Stromal Cells and Their Rejection Mediated by Intrahepatic NK Cells.

Authors:  Jing-Jing Liu; Xiao-Jun Hu; Zheng-Ran Li; Rong-Hua Yan; Dan Li; Jin Wang; Hong Shan
Journal:  Mol Imaging Biol       Date:  2017-02       Impact factor: 3.488

Review 6.  NK cells after transplantation: friend or foe.

Authors:  Uzi Hadad; Olivia Martinez; Sheri M Krams
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

Review 7.  Natural killer cells in inflammatory heart disease.

Authors:  SuFey Ong; Noel R Rose; Daniela Čiháková
Journal:  Clin Immunol       Date:  2016-11-25       Impact factor: 3.969

Review 8.  The significance of non-T-cell pathways in graft rejection: implications for transplant tolerance.

Authors:  Xian Chang Li
Journal:  Transplantation       Date:  2010-11-27       Impact factor: 4.939

Review 9.  Adaptive features of innate immune cells and their relevance to graft rejection.

Authors:  Guangchuan Wang; Gangcheng Kong; Xian C Li
Journal:  Curr Opin Organ Transplant       Date:  2019-12       Impact factor: 2.640

10.  Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo.

Authors:  Olivier Morteau; Samkeliso Blundell; Aron Chakera; Sophia Bennett; Charita M Christou; Philip D Mason; Richard J Cornall; Christopher A O'Callaghan
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.